The intergroup rhabdomyosarcoma study: a preliminary report

Cancer. 1977 Nov;40(5):2015-26. doi: 10.1002/1097-0142(197711)40:5<2015::aid-cncr2820400505>3.0.co;2-k.
No abstract available

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Child
  • Child, Preschool
  • Clinical Trials as Topic
  • Cyclophosphamide / therapeutic use
  • Dactinomycin / therapeutic use
  • Drug Therapy, Combination
  • Evaluation Studies as Topic
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Lymphatic Metastasis
  • Male
  • Neoplasm Staging
  • Prognosis
  • Prospective Studies
  • Rhabdomyosarcoma / pathology
  • Rhabdomyosarcoma / therapy*
  • Vincristine / therapeutic use

Substances

  • Antineoplastic Agents
  • Dactinomycin
  • Vincristine
  • Cyclophosphamide